Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice

Steatosis has a low tolerance against ischemia-reperfusion injury (IRI). To prevent IRI in the steatotic liver, we attempted to elucidate the protective effect of astaxanthin (ASTX) in the steatotic liver model by giving mice a methionine and choline-deficient high fat (MCDHF) diet. Levels of lipid peroxidation and apoptosis, the expression of inflammatory cytokines and heme oxygenase (HO)-1, in the liver were assessed. Reactive oxygen species (ROS), inflammatory cytokines, apoptosis-related proteins and members of the signaling pathway were also examined in isolated Kupffer cells and/or hepatocytes from the steatotic liver. ASTX decreased serum ALT and AST levels, the amount of TUNEL, F4/80, or 4HNE-positive cells and the mRNA levels of inflammatory cytokines in MCDHF mice by IRI. Moreover, HO-1 and HIF-1α, phosphorylation of Akt and mTOR expressions were increased by ASTX. The inflammatory cytokines produced by Kupffer, which were subjected to hypoxia and reoxygenation (HR), were inhibited by ASTX. Expressions of Bcl-2, HO-1 and Nrf2 in hepatocytes by HR were increased, whereas Caspases activation, Bax and phosphorylation of ERK, MAPK, and JNK were suppressed by ASTX. Pretreatment with ASTX has a protective effect and is a safe therapeutic treatment for IRI, including for liver transplantation of the steatotic liver.

[1]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[2]  T. Sugiyama,et al.  5-Aminolevulinic acid combined with ferrous iron ameliorate ischemia-reperfusion injury in the mouse fatty liver model. , 2016, Biochemical and biophysical research communications.

[3]  Philipp Dutkowski,et al.  Liver transplantation using fatty livers: always feasible? , 2011, Journal of hepatology.

[4]  H. de Groot,et al.  O2-. release by activated Kupffer cells upon hypoxia-reoxygenation. , 1991, The American journal of physiology.

[5]  J. Sznajder,et al.  Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[6]  A. Gerbes,et al.  Preservation injury of the liver: mechanisms and novel therapeutic strategies. , 2000, Journal of hepatology.

[7]  T. Maoka,et al.  Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice , 2004, BioFactors.

[8]  A. Phillips,et al.  Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia-reperfusion injury: a systematic review. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  A. Kong,et al.  Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  Fan Wang,et al.  Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice , 2015, Marine drugs.

[11]  Xuebo Liu,et al.  Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer. , 2007, Biochemical and biophysical research communications.

[12]  J. Gugenheim,et al.  Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. , 2003, European journal of pharmacology.

[13]  A. Farhood,et al.  Mechanism of cell death during warm hepatic ischemia‐reperfusion in rats: Apoptosis or necrosis? , 2001, Hepatology.

[14]  S. Akira,et al.  Lipopolysaccharide-Induced IL-18 Secretion from Murine Kupffer Cells Independently of Myeloid Differentiation Factor 88 That Is Critically Involved in Induction of Production of IL-12 and IL-1β1 , 2001, The Journal of Immunology.

[15]  M. Trauner,et al.  Fatty liver and lipotoxicity. , 2010, Biochimica et biophysica acta.

[16]  E. Camera,et al.  Astaxanthin, canthaxanthin and β‐carotene differently affect UVA‐induced oxidative damage and expression of oxidative stress‐responsive enzymes , 2009, Experimental dermatology.

[17]  T. Yokozawa,et al.  Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. , 2009, Journal of agricultural and food chemistry.

[18]  Hui Shen,et al.  Astaxanthin reduces ischemic brain injury in adult rats , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  G. Park,et al.  Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells. , 2011, Cancer letters.

[20]  H. Jaeschke,et al.  Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. , 1991, The American journal of physiology.

[21]  Y. Zhai,et al.  Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation , 2011, American Journal of Transplantation.

[22]  Jiahuai Han,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.

[23]  S. Kaneko,et al.  Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E , 2015, Scientific Reports.

[24]  H. Hara,et al.  Astaxanthin Protects Against Retinal Damage: Evidence from In Vivo and In Vitro Retinal Ischemia and Reperfusion Models , 2016, Current eye research.

[25]  L. Toledo-Pereyra,et al.  Role of p38 and JNK in liver ischemia and reperfusion. , 2009, Journal of hepato-biliary-pancreatic surgery.

[26]  D. Tripathi,et al.  Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. , 2010, Mutation research.

[27]  G. Park,et al.  ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells. , 2014, International journal of oncology.

[28]  Gokare A. Ravishankar,et al.  In vivo bioavailability and antioxidant activity of carotenoids from microalgal biomass — A repeated dose study , 2013 .

[29]  X. Gu,et al.  Protective effects of astaxanthin against ischemia/reperfusion induced renal injury in mice , 2015, Journal of Translational Medicine.

[30]  Chao-Ching Huang,et al.  Ischemic Preconditioning Reduces Neurovascular Damage After Hypoxia-Ischemia Via the Cellular Inhibitor of Apoptosis 1 in Neonatal Brain , 2013, Stroke.

[31]  S. Hand,et al.  Mitochondria in energy-limited states: mechanisms that blunt the signaling of cell death , 2008, Journal of Experimental Biology.

[32]  N. Demir,et al.  Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. , 2010, Toxicology.

[33]  T. Tang,et al.  Pro-Inflammatory Activated Kupffer Cells by Lipids Induce Hepatic NKT Cells Deficiency through Activation-Induced Cell Death , 2013, PloS one.

[34]  Gokare A. Ravishankar,et al.  Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis. , 2008, European journal of pharmacology.

[35]  J. Contreras,et al.  17beta-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice. , 2005, Transplantation proceedings.

[36]  Hong Wang,et al.  Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-κB pathway. , 2013, International journal of molecular medicine.

[37]  D. Long,et al.  Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line. , 2006, Transplantation proceedings.

[38]  D. Andrews,et al.  Shedding Light on Apoptosis at Subcellular Membranes , 2012, Cell.

[39]  Chi-Tang Ho,et al.  Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. , 2015, Journal of agricultural and food chemistry.

[40]  R. Freeman,et al.  Report of the Paris consensus meeting on expanded criteria donors in liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[41]  Gokare A. Ravishankar,et al.  Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications—A Review , 2014, Marine drugs.

[42]  J. Haddad.  The role of Bax/Bcl-2 and pro-caspase peptides in hypoxia/reperfusion-dependent regulation of MAPK(ERK): discordant proteomic effect of MAPK(p38). , 2007, Protein Peptide Letters.

[43]  Zhimin Lu,et al.  ERK1/2 MAP kinases in cell survival and apoptosis , 2006, IUBMB life.

[44]  Q. Xiao,et al.  Mild hypothermia pretreatment protects hepatocytes against ischemia reperfusion injury via down-regulating miR-122 and IGF-1R/AKT pathway. , 2017, Cryobiology.

[45]  I. Carmody,et al.  TIMP-3 Ameliorates Hepatic Ischemia/Reperfusion Injury Through Inhibition of Tumor Necrosis Factor-Alpha-Converting Enzyme Activity in Rats , 2006, Transplantation.

[46]  T. M. Gulik,et al.  Sterile inflammation in hepatic ischemia/reperfusion injury: Present concepts and potential therapeutics , 2013, Journal of gastroenterology and hepatology.

[47]  P. Newsome,et al.  Non-alcoholic fatty liver disease and liver transplantation. , 2016, Metabolism: clinical and experimental.

[48]  M. Grisham,et al.  Selected contribution: Effects of gender on reduced-size liver ischemia and reperfusion injury. , 2001, Journal of applied physiology.

[49]  Yilin Yang,et al.  Cytoprotection against Hypoxic and/or MPP+ Injury: Effect of δ–Opioid Receptor Activation on Caspase 3 , 2016, International journal of molecular sciences.